IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 3 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,580 | -54.3% | 1,226,400 | -29.2% | 0.01% | -44.4% |
| Q2 2023 | $12,198 | +6.4% | 1,732,700 | -7.6% | 0.02% | +20.0% |
| Q1 2023 | $11,459 | -44.0% | 1,875,500 | -41.4% | 0.02% | -46.4% |
| Q4 2022 | $20,454 | -99.7% | 3,200,900 | +295.9% | 0.03% | +154.5% |
| Q3 2022 | $7,746,000 | +50.3% | 808,600 | +199.5% | 0.01% | +83.3% |
| Q4 2021 | $5,154,000 | +15.8% | 270,000 | +92.0% | 0.01% | 0.0% |
| Q1 2021 | $4,451,000 | +298.5% | 140,600 | +129.0% | 0.01% | +500.0% |
| Q3 2019 | $1,117,000 | – | 61,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |